Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Instant NanoBiosensors has developed commercial platforms for ultra-sensitive blood biomarker detection—especially targeting early diagnosis of Alzheimer’s—and advanced gene mutation testing solutions for leukemia. Their FOPPR™ technology enables real-time detection at fg/mL sensitivity with a wide dynamic range. The company collaborates internationally on Alzheimer's diagnostics and has received support from the EU and the Alzheimer’s Drug Discovery Foundation. Their products are used in research labs, hospitals, and clinical settings across multiple countries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Instant NanoBiosensors.